| |
Latest 10 SEC filings (by transaction date) for BRTX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 10/24 | Apr 9/24 | Silva Francisco | Direct Ownership | Common Stock | P - Open market or private purchase | 6,600 | $1.25 |
Apr 10/24 | Apr 8/24 | Silva Francisco | Direct Ownership | Common Stock | P - Open market or private purchase | 1,232 | $1.17 |
Apr 10/24 | Apr 8/24 | Silva Francisco | Direct Ownership | Common Stock | P - Open market or private purchase | 476 | $1.13 |
Mar 20/24 | Mar 18/24 | Silva Francisco | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -17,193 | $1.39 |
Mar 20/24 | Mar 18/24 | Alstodt Lance | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -17,633 | $1.39 |
Feb 15/24 | Feb 13/24 | Rosa David A | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 79,646 | |
Feb 15/24 | Feb 13/24 | Williams Patrick F. | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 79,646 | |
Feb 15/24 | Feb 13/24 | Kukekov Nickolay V. | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 79,646 | |
Feb 15/24 | Feb 13/24 | Paccasassi Robert | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 219,298 | |
Feb 15/24 | Feb 13/24 | Kristal Robert Eugene | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 263,158 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for BRTX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 10/24 | Apr 9/24 | Silva Francisco | Direct Ownership | Common Stock | P - Open market or private purchase | 6,600 | $1.25 |
Apr 10/24 | Apr 8/24 | Silva Francisco | Direct Ownership | Common Stock | P - Open market or private purchase | 1,232 | $1.17 |
Apr 10/24 | Apr 8/24 | Silva Francisco | Direct Ownership | Common Stock | P - Open market or private purchase | 476 | $1.13 |
Mar 20/24 | Mar 18/24 | Silva Francisco | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -17,193 | $1.39 |
Mar 20/24 | Mar 18/24 | Alstodt Lance | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -17,633 | $1.39 |
Feb 15/24 | Feb 13/24 | Rosa David A | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 79,646 | |
Feb 15/24 | Feb 13/24 | Williams Patrick F. | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 79,646 | |
Feb 15/24 | Feb 13/24 | Kukekov Nickolay V. | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 79,646 | |
Feb 15/24 | Feb 13/24 | Paccasassi Robert | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 219,298 | |
Feb 15/24 | Feb 13/24 | Kristal Robert Eugene | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 263,158 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |